Methyl 4-azaindole-2-carboxylate
CAS: 394223-19-9
Ref. 3D-UQA22319
1g | Descontinuado | ||
5g | Descontinuado | ||
100mg | Descontinuado | ||
250mg | Descontinuado | ||
500mg | Descontinuado |
Informação sobre produto
- 1H-Pyrrolo[3,2-b]pyridine-2-carboxylic acid, methyl ester
- Methyl 1H-pyrrolo[3,2-b]pyridine-2-carboxylate
- Methyl 1H-pyrrolo[3,2-b]pyridine-2-carboxylate
Methyl 4-azaindole-2-carboxylate is an experimental treatment for babesiosis. It is a glycol ester of a fatty acid that has been shown to be effective in the chemotherapeutic treatment of splenectomized animals and those with other forms of immunosuppression. Methyl 4-azaindole-2-carboxylate is antigenic and virulent, but does not seem to cause disease in healthy animals. Methyl 4-azaindole-2-carboxylate is being studied as a potential diagnostic tool for infectious diseases, such as malaria and babesiosis, which are caused by the Plasmodium parasite. The methyl 4-azaindole-2-carboxylate antigen can be detected using serological tests, such as agarose gel electrophoresis or enzyme linked immunosorbent assay (ELISA).